WO2006054536A1 - 尿路結石症治療剤 - Google Patents
尿路結石症治療剤 Download PDFInfo
- Publication number
- WO2006054536A1 WO2006054536A1 PCT/JP2005/020912 JP2005020912W WO2006054536A1 WO 2006054536 A1 WO2006054536 A1 WO 2006054536A1 JP 2005020912 W JP2005020912 W JP 2005020912W WO 2006054536 A1 WO2006054536 A1 WO 2006054536A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ethyl
- chemical
- active ingredient
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004331711 | 2004-11-16 | ||
JP2004-331711 | 2004-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006054536A1 true WO2006054536A1 (ja) | 2006-05-26 |
Family
ID=36407079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/020912 WO2006054536A1 (ja) | 2004-11-16 | 2005-11-15 | 尿路結石症治療剤 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006054536A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04275221A (ja) * | 1991-03-01 | 1992-09-30 | Taisho Pharmaceut Co Ltd | 制癌効果増強剤 |
JPH05194179A (ja) * | 1992-01-21 | 1993-08-03 | Kanebo Ltd | 皮膚化粧料 |
JPH10504550A (ja) * | 1994-08-25 | 1998-05-06 | ヘキスト・アクチエンゲゼルシヤフト | 免疫疾患に使用するための複合製剤 |
JP2000502676A (ja) * | 1995-12-22 | 2000-03-07 | リヒター ゲデオン ベジェセティ ジャール アール.テー | 薬剤としてのトランスアポビンカミン酸エステル誘導体 |
JP2002526442A (ja) * | 1998-09-23 | 2002-08-20 | 藤沢薬品工業株式会社 | プロスタグランジンe2アンタゴニストの新規用途 |
-
2005
- 2005-11-15 WO PCT/JP2005/020912 patent/WO2006054536A1/ja not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04275221A (ja) * | 1991-03-01 | 1992-09-30 | Taisho Pharmaceut Co Ltd | 制癌効果増強剤 |
JPH05194179A (ja) * | 1992-01-21 | 1993-08-03 | Kanebo Ltd | 皮膚化粧料 |
JPH10504550A (ja) * | 1994-08-25 | 1998-05-06 | ヘキスト・アクチエンゲゼルシヤフト | 免疫疾患に使用するための複合製剤 |
JP2000502676A (ja) * | 1995-12-22 | 2000-03-07 | リヒター ゲデオン ベジェセティ ジャール アール.テー | 薬剤としてのトランスアポビンカミン酸エステル誘導体 |
JP2002526442A (ja) * | 1998-09-23 | 2002-08-20 | 藤沢薬品工業株式会社 | プロスタグランジンe2アンタゴニストの新規用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101918669B1 (ko) | 신경 장애 치료용 신규 조성물 | |
US5945416A (en) | Method for treating pain | |
EA004930B1 (ru) | Фармацевтическая композиция для лечения острой, хронической боли и/или невропатической боли и мигреней | |
KR20180043844A (ko) | 바클로펜 및 아캄프로세이트에 기초한 신경 장애의 치료 | |
CZ288984B6 (cs) | Farmaceutický prostředek k inhibici Alzheimerovy nemoci, ke zvyąování TGF-beta exprese v mozku, k inhibici zánětlivé odezvy spojené s Alzheimerovou nemocí a k inhibici neurotoxicity zprostředkované beta-amyloidním peptidem | |
KR102475124B1 (ko) | sGC 자극제를 사용한 CNS 질환의 치료 | |
TW201208667A (en) | Pharmaceutical combinations | |
JP2019502686A (ja) | 消化管括約筋機能障害の治療へのsGC刺激薬の使用 | |
KR20080105105A (ko) | 인지 장애 및 기타 장애의 치료방법 | |
RU2493851C2 (ru) | Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинестеразы, содержащая ее фармацевтическая композиция и ее применение в лечении когнитивных расстройств | |
AU2014252219B2 (en) | NSAID administration and related compositions, methods and systems. | |
KR102513343B1 (ko) | sGC 자극제의 인 전구약물 | |
US20110021542A1 (en) | Use of a Combination of Udenafil and Alfuzosin or Oxybutynin for the Treatment of Overactive Bladder | |
CA3073186C (en) | Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate | |
WO2006054536A1 (ja) | 尿路結石症治療剤 | |
US4970202A (en) | Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs | |
HUT72297A (en) | Pharmaceutical compositions for inhibiting the effects of amyloidogenic proteins containing benzotiophene derivatives and process for their preparation | |
JP2002503224A (ja) | 疼痛を処置するための組成物 | |
JP2000026313A (ja) | 消化管運動抑制剤 | |
JP2004002454A (ja) | 消化管運動抑制剤 | |
CN107773560A (zh) | 一种具有止痛和消炎作用的药用组合物 | |
KR20000004965A (ko) | 통증 치료 방법 | |
JPS63162624A (ja) | 良性前立腺肥大症の症状軽減用医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05807001 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |